CalcMyPeptide
Khavinson BioregulatorAlso known as: Lung Extract Bioregulator, Pulmonary Cytomax

Honluten

Honluten is the premier Cytomax natural bioregulator for profound respiratory regeneration, utilizing highly complex peptide fractions extracted from the lungs of young animals. Operating as the natural, full-spectrum counterpart to synthetic Bronchogen, it is aggressively deployed in clinical settings to physically rehabilitate lungs ravaged by chronic smoking, severe systemic viral insults, and the debilitating decline of deep alveolar capacity characteristic of advanced age.

Reviewed by CalcMyPeptide Editorial Team
Last updated: April 2026Evidence: Low

Quick Stats

Half-LifeMixture (variable)
Dose Range1-2 capsules/day
Frequency1-2× daily for 10-30 day cycles
Vial SizesN/A (oral)
BioavailabilityOral capsules
Year Developed1980s

Scientific Data

Molecular Formula
Polypeptide extract (Lung tissue <10 kDa)
Molecular Weight
Mixture (<10 kDa)
PubChem ID

Mechanism of Action

Honluten is a Cytomax natural polypeptide extract from the lung and bronchial mucosa of young calves, delivering peptide signals to human alveolar type II pneumocytes, bronchial epithelial cells, and pulmonary interstitial cells to restore age-silenced gene expression governing surfactant production, mucociliary clearance, and alveolar repair capacity. It is the natural broad-spectrum lung extract counterpart to the targeted synthetic lung peptides Chonluten (Lys-Glu-Asp tripeptide) and Bronchogen (Ala-Glu-Asp-Leu tetrapeptide).

The lungs are one of the most metabolically exposed organs: over 10,000 liters of air pass through daily, delivering particulates, oxidants, pathogens, and irritants directly to the bronchial epithelium. Alveolar surface area declines ~4 m² per decade after age 30, and surfactant protein D (SP-D) production falls with age, reducing innate pathogen neutralization at the lung surface. Mucociliary clearance also slows, allowing inhaled particulates to accumulate in the small airways.

Honluten delivers short peptide signals (<10 kDa) from bovine lung/bronchial tissue to reactivate genes encoding: surfactant proteins B and D (SP-B, SP-D), CFTR (airway surface liquid maintenance), ciliogenesis factors (FOXJ1), and IL-10 (bronchial anti-inflammatory). Unlike Taxorest (A-19, which targets primarily bronchial mucosa), Honluten is sourced from both alveolar and bronchial components giving it a broader pulmonary coverage. In Khavinson's system, Honluten is used sequentially or in combination with Taxorest for enhanced respiratory recovery.

Source: PMID: 15677927

Background & History

Honluten is the lung Cytomax extract, providing broad pulmonary peptide support.

Research Use Cases

  • Pulmonary function
  • Respiratory health
  • Chronic lung conditions

Dosing Protocol

Typical Dose1-2 capsules/day
Frequency1-2× daily for 10-30 day cycles
Half-Life~30 minutes (estimated)

Dosing Protocols

Mini-Course / General Preventive (1 box)

Dose
2 capsules (20 mg)
Frequency
Once daily for 10 days, 30 min before meals
Note: Standard Khavinson mini-course (20 caps). Repeat every 6 months. Combine with Taxorest (A-19) for comprehensive bronchial + alveolar lung coverage.

Full Monthly Course (Respiratory Recovery / Chronic Lung Support)

Dose
2 capsules (20 mg)
Frequency
Twice daily for 30 days (120 caps = 2× 60-cap boxes)
Note: Bi-annual 30-day courses for post-COVID lung recovery, COPD stages I–II, or chronic bronchitis. Core pulmonary stack: Honluten + Taxorest (A-19) + Ventfort (A-3) for alveolar-bronchial-vascular lung health.

Intensive / Pulmonary Restoration Protocol

Dose
2 capsules (20 mg)
Frequency
Twice daily, repeated monthly
Note: Post-pneumonia recovery, occupational lung exposure (silica, dust), or significant post-COVID lung remodeling. Physician supervision required. Max: 4 caps/day (40 mg).

Administration

Route
Oral capsules (20-cap and 60-cap boxes)
Timing
30 minutes before meals. Morning + evening for intensive courses.
Fasting Required?
Yes — inject on an empty stomach

Expected Timeline

Days 1—14
Pulmonary epithelial gene expression restoration initiated. Early improvement in airway mucus clearance reported.
Month 1–2
Improved respiratory stamina, reduced chronic cough, better alveolar gas exchange.
Month 3–6
Sustained alveolar integrity improvement. Reduced frequency of respiratory infections.

Who Is It For?

Post-COVID / Viral Pulmonary Recovery

Low

Targets alveolar type II pneumocyte and bronchial epithelial gene expression. Addresses the mucosal and alveolar damage component of post-viral respiratory syndromes.

COPD / Chronic Bronchitis Support (Adjunct)

Low

Complementary to standard COPD management. Works at the cellular gene program level to support bronchial mucosal integrity over time.

Safety & Considerations

Natural glandular extract (Cytomax) from bovine lung/bronchial tissue, <10 kDa. No hormones. Meets European/Russian veterinary standards. Generally recognized as safe.

Regulatory & Legal Status

FDA Status (US)
Research Only
WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Interactions & Contraindications

Standard Cytomax capsule protocol.

Synergies & Common Stacks

Honluten (lung Cytomax) + Bronchogen (synthetic bronchial) = comprehensive respiratory bioregulator support.

Dosing Quick Reference

Honluten— Dosing Guide
Dose Range
1-2 capsules/day
Half-Life
~30 minutes (estimated)
Frequency
1-2× daily for 10-30 day cycles
Route
Oral
Khavinson Bioregulatorcalcmypeptide.com

Frequently Asked Questions

How does Honluten compare to Chonluten?
Honluten is the broad-spectrum natural Cytomax extract containing >40 peptide fragments from bovine lung/bronchial tissue. Chonluten (Lys-Glu-Asp) is a concentrated synthetic tripeptide targeting specific lung cell receptors with faster onset. Honluten provides broader transcriptional restoration across multiple cell types; Chonluten provides a more targeted, rapid molecular hit. Many practitioners use them sequentially in recovery protocols.
Why is Honluten separate from Taxorest (A-19)?
Taxorest (A-19) is derived specifically from bronchial mucosa cells (Clara cells, bronchial epithelium). Honluten includes both bronchial and alveolar tissue in its extraction, giving it broader pulmonary coverage. They complement each other: Taxorest for bronchial mucociliary clearance and mucin production; Honluten for alveolar type II pneumocytes and surfactant production.

📚 Related Articles

Recommended SourceOral Bioregulator

Get Honluten from Vita-Stream — the comprehensive distributor for authentic Khavinson bioregulators. Oral capsules, no injections required.

Affiliate link · Full review